TG Therapeutics, Inc. (TGTX)

TG Therapeutics Revenue

TG Therapeutics had revenue of $240.34M in the quarter ending June 30, 2026, with 70.27% growth. This brings the company's total for the last twelve months to $799.54M, up 76.08% year-over-year. In the year 2025, TG Therapeutics had annual revenue of $616.29M with 87.32% growth. That makes TG Therapeutics the 8,689th largest company in the world by revenue and 1,944th in the United States.

• Revenue (ttm): $799.54M
• Revenue Growth: +76.08%
• P/S Ratio: 9.67
• Revenue / Employee: $2,003,850
• Employees: 399
• Market Cap: 7.73B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Product Revenue, Net 606.93M 98.5%
• Royalty 5.62M 0.9%
• Other 3.59M 0.6%
• License 152.00K 0.0%

By Geography

• United States 594.11M 97.9%
• International 12.82M 2.1%

Fiscal year ended Dec 31, 2025 See the full TG Therapeutics breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	616.29M	287.28M	87.32%
Dec 31, 2024	329.00M	95.34M	40.80%
Dec 31, 2023	233.66M	230.88M	8,290.02%
Dec 31, 2022	2.79M	-3.90M	-58.36%
Dec 31, 2021	6.69M	6.54M	4,300.66%
Dec 31, 2020	152.00K	-	-
Dec 31, 2019	152.00K	-	-
Dec 31, 2018	152.00K	-	-
Dec 31, 2017	152.00K	-	-
Dec 31, 2016	152.00K	-381.00	-0.25%
Dec 31, 2015	152.38K	-	-
Dec 31, 2014	152.38K	-	-
Dec 31, 2013	152.38K	133.33K	699.98%
Dec 31, 2012	19.05K	-	-
Dec 31, 2011	-	-	-
Dec 31, 2010	-	-	-
Dec 31, 2009	-	-	-
Dec 31, 2008	-	-	-
Dec 31, 2007	-	-	-
Dec 31, 2006	-	-	-

Data Sources: Fiscal.ai and S&P Global Market Intelligence Last updated: Aug 5, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company. Revenue geography data is provided by S&P Global Market Intelligence.

Update frequency:

Quarterly

Last checked:

Oct 17, 2026

Data Sources Report a data error